HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julia Y S Tsang Selected Research

Estrogen Receptors

1/2017Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast Cancers.
10/2015Anterior Gradient 2 is a Poor Outcome Indicator in Luminal Breast Cancer.
4/2013Nerve growth factor receptor (NGFR): a potential marker for specific molecular subtypes of breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julia Y S Tsang Research Topics

Disease

31Neoplasms (Cancer)
01/2024 - 09/2012
25Breast Neoplasms (Breast Cancer)
01/2024 - 09/2012
7Necrosis
01/2024 - 12/2013
3Triple Negative Breast Neoplasms
11/2018 - 09/2012
2Alzheimer Disease (Alzheimer's Disease)
12/2018 - 11/2018
2Neoplasm Metastasis (Metastasis)
01/2017 - 10/2015
1Granulomatous Mastitis
04/2023
1Inflammation (Inflammations)
04/2023
1Lymphatic Metastasis
11/2018
1Carcinogenesis
11/2018
1Tertiary Lymphoid Structures
11/2017
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2016
1Carcinoma (Carcinomatosis)
03/2014
1Phyllodes Tumor (Cystosarcoma Phylloides)
12/2012

Drug/Important Bio-Agent (IBA)

19Biomarkers (Surrogate Marker)IBA
01/2020 - 09/2012
14Phenobarbital (Luminal)FDA Link
10/2020 - 11/2012
6Proteins (Proteins, Gene)FDA Link
10/2020 - 11/2013
5Indicators and Reagents (Reagents)IBA
11/2017 - 11/2012
4Progesterone Receptors (Progesterone Receptor)IBA
10/2020 - 04/2013
3Estrogen ReceptorsIBA
01/2017 - 04/2013
3Cadherins (E-Cadherin)IBA
01/2016 - 12/2012
2VimentinIBA
10/2020 - 12/2013
2human ERBB2 proteinIBA
12/2018 - 12/2013
2Amyloid (Amyloid Fibrils)IBA
12/2018 - 11/2018
2ErbB Receptors (EGF Receptor)IBA
12/2017 - 07/2013
2Androgen Receptors (Androgen Receptor)IBA
12/2016 - 07/2014
2Crystallins (Crystallin)IBA
08/2013 - 09/2012
1Immunoglobulin M (IgM)IBA
04/2023
1Proline (L-Proline)FDA Link
04/2019
1Leucine (L-Leucine)FDA Link
04/2019
1Glutamic Acid (Glutamate)FDA Link
04/2019
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
04/2019
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
03/2019
1Small Interfering RNA (siRNA)IBA
12/2018
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
12/2018
1Growth Factor ReceptorsIBA
11/2018
1MucinsIBA
12/2017
1Hyaluronic Acid (Hyaluronan)IBA
12/2016
1IsoenzymesIBA
12/2016
1Hyaluronan SynthasesIBA
12/2016
1SynaptophysinIBA
01/2016
1Tumor Biomarkers (Tumor Markers)IBA
01/2016
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
01/2016
1Phosphotransferases (Kinase)IBA
01/2016
1Doublecortin-Like KinasesIBA
01/2016
1Carrier Proteins (Binding Protein)IBA
07/2015
1Hormones (Hormone)IBA
07/2014
1SteroidsIBA
07/2014
1Monoclonal AntibodiesIBA
03/2014
1AntibodiesIBA
03/2014
1AntigensIBA
11/2013
1Cell Adhesion MoleculesIBA
11/2013
1Carcinoembryonic AntigenIBA
11/2013
1ChemokinesIBA
08/2013
1Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
04/2013
1Aldehyde DehydrogenaseIBA
11/2012
1Complement System Proteins (Complement)IBA
11/2012
1Keratins (Keratin)IBA
09/2012

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2024 - 11/2018
2Therapeutics
11/2018 - 09/2014
1Neoadjuvant Therapy
01/2024